Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G W Amsden

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Expert Opinion on Pharmacotherapy|March 16, 2001
Azithromycin: indications for the future?J M Duran, G W Amsden
Drugs|March 29, 2001
Interpretation of antibacterial susceptibility reports: in vitro versus clinical break-pointsG W Amsden, J M Duran
Antimicrobial Agents and Chemotherapy|April 4, 1998
Bronchopulmonary pharmacokinetics of clarithromycin and azithromycinA D Kashuba, G W Amsden
Pharmacotherapy|September 1, 1996
Prospective validation of an optimal sparse plasma-sampling strategy for estimating ciprofloxacin pharmacokineticsG W Amsden, C H Ballow
Pharmacotherapy|January 23, 1999
Trovafloxacin: an overviewK W Garey, G W Amsden
The Annals of Pharmacotherapy|March 13, 1998
Current issues in onychomycosisE F Trépanier, G W Amsden
The Journal of Antimicrobial Chemotherapy|January 11, 2001
Serum and WBC pharmacokinetics of 1500 mg of azithromycin when given either as a single dose or over a 3 day period in healthy volunteersG W Amsden, C L Gray
The Annals of Pharmacotherapy|March 20, 1999
Intravenous azithromycinK W Garey, G W Amsden
The Annals of Pharmacotherapy|October 1, 1995
Treatment of non-HIV cryptosporidial diarrhea with azithromycinR E Bessette, G W Amsden
Clinical Drug Investigation|January 15, 2013
Pharmacokinetic study of azithromycin with fluconazole and cotrimoxazole (trimethoprim-sulfamethoxazole) in healthy volunteersG W Amsden, G Foulds, K Thakker
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Expert Opinion on Pharmacotherapy|March 16, 2001
Azithromycin: indications for the future?J M Duran, G W Amsden
Drugs|March 29, 2001
Interpretation of antibacterial susceptibility reports: in vitro versus clinical break-pointsG W Amsden, J M Duran
Antimicrobial Agents and Chemotherapy|April 4, 1998
Bronchopulmonary pharmacokinetics of clarithromycin and azithromycinA D Kashuba, G W Amsden
Pharmacotherapy|September 1, 1996
Prospective validation of an optimal sparse plasma-sampling strategy for estimating ciprofloxacin pharmacokineticsG W Amsden, C H Ballow
Pharmacotherapy|January 23, 1999
Trovafloxacin: an overviewK W Garey, G W Amsden
The Annals of Pharmacotherapy|March 13, 1998
Current issues in onychomycosisE F Trépanier, G W Amsden
The Journal of Antimicrobial Chemotherapy|January 11, 2001
Serum and WBC pharmacokinetics of 1500 mg of azithromycin when given either as a single dose or over a 3 day period in healthy volunteersG W Amsden, C L Gray
The Annals of Pharmacotherapy|March 20, 1999
Intravenous azithromycinK W Garey, G W Amsden
The Annals of Pharmacotherapy|October 1, 1995
Treatment of non-HIV cryptosporidial diarrhea with azithromycinR E Bessette, G W Amsden
Clinical Drug Investigation|January 15, 2013
Pharmacokinetic study of azithromycin with fluconazole and cotrimoxazole (trimethoprim-sulfamethoxazole) in healthy volunteersG W Amsden, G Foulds, K Thakker
Pageof 4